PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA.\', \'Department of Medicine, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA fmarty@bwh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e01814-2010.1128/AAC.01814-20
?:hasPublicationType
?:journal
  • Antimicrobial agents and chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33139290
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.291
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all